Species‐dependent differences in the properties of particulate cyclic nucleotide phosphodiesterase from rat and rabbit ventricular myocardium
暂无分享,去创建一个
[1] M. Shahid,et al. Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: role of phosphodiesterase inhibition , 1989, British journal of pharmacology.
[2] S. Jackman,et al. The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re‐uptake site , 1989, British journal of pharmacology.
[3] H. C. Hartzell,et al. Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes. , 1988, Molecular pharmacology.
[4] M. Artman,et al. Subcellular Distribution of High‐Affinity Type IV Cyclic AMP Phosphodiesterase Activity in Rabbit Ventricular Myocardium: Relations to the Effects of Cardiotonic Drugs , 1988, Circulation research.
[5] H. R. Kaplan,et al. Subclasses of Cyclic AMP‐Specific Phosphodiesterase in Left Ventricular Muscle and Their Involvement in Regulating Myocardial Contractility , 1987, Circulation research.
[6] P. J. England,et al. The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors. , 1987, The Biochemical journal.
[7] A. Rhoads,et al. Particulate cyclic 3',5'-nucleotide phosphodiesterase and calmodulin of cardiac muscle. , 1984, The International journal of biochemistry.
[8] E. Miyamoto,et al. Multiple cyclic nucleotide phosphodiesterase activities from rat tissues and occurrence of a calcium-plus-magnesium-ion-dependent phosphodiesterase and its protein activator. , 1975, The Biochemical journal.